ZLAB
Zai Lab Ltd
NASDAQ: ZLAB · HEALTHCARE · BIOTECHNOLOGY
$20.75
-6.28% today
Updated 2026-04-29
Market cap
$2.33B
P/E ratio
—
P/S ratio
5.07x
EPS (TTM)
$-1.60
Dividend yield
—
52W range
$16 – $44
Volume
0.8M
Zai Lab Ltd (ZLAB) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
-7.1%
Last 4 quarters
Revenue YoY growth
+17.0%
Most recent quarter
EPS YoY growth
+42.5%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-7.4%
Last 3 reports
Positive reaction rate
0%
0 of 3 quarters
Largest single-day move
-11.7%
2025-11-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-26 | $-0.46 | -23.9% | $19.39 | $19.22 | -0.9% |
| 2025-11-06 | $-0.33 | -32.0% | $24.80 | $21.90 | -11.7% |
| 2025-08-07 | $-0.37 | +9.8% | $38.72 | $34.96 | -9.7% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.37 | $-0.46 | -23.9% | $127.60M | +17.0% |
| 2025-09-30 | $-0.25 | $-0.33 | -32.0% | $116.09M | +13.5% |
| 2025-06-30 | $-0.41 | $-0.37 | +9.8% | $109.98M | +9.4% |
| 2025-03-31 | $-0.55 | $-0.45 | +17.8% | $106.49M | +22.2% |
| 2024-12-31 | $-0.63 | $-0.80 | -26.3% | $109.07M | +65.7% |
| 2024-09-30 | $-0.78 | $-0.42 | +46.2% | $102.27M | +47.7% |
| 2024-06-30 | $-0.71 | $-0.80 | -12.7% | $100.50M | +45.9% |
| 2024-03-31 | $-0.92 | $-0.50 | +45.7% | $87.15M | — |
| 2023-12-31 | $-0.86 | $-1.00 | -16.3% | $65.83M | — |
| 2023-09-30 | $-1.04 | $-0.71 | +31.7% | $69.23M | — |
| 2023-06-30 | $-0.79 | $-1.25 | -58.2% | $68.86M | — |
Frequently asked questions
Has Zai Lab Ltd beaten earnings estimates?
Zai Lab Ltd has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of -7.1% over the last 4 quarters.
How does ZLAB stock react to earnings?
ZLAB stock has moved an average of -7.4% in the trading day following earnings over its last 3 reports, with positive reactions in 0% of those quarters.
What is Zai Lab Ltd's revenue growth rate?
Zai Lab Ltd reported year-over-year revenue growth of +17.0% in its most recent quarter, with EPS growing +42.5% year-over-year.